
News


Applied Clinical Trials
Democratic candidate Hillary Clinton is introducing her Prescription Drug Plan which is meant to benefit patients, however, will Hillary’s plan be good for advancing novel therapies, and will it benefit R&D organizations?

Applied Clinical Trials
Addressing the challenges unique to purely industry-sponsored trials is explored.

Applied Clinical Trials
The successful implementation of centralized monitoring requires effective planning, process restructuring, cross-functional expertise alignment, and the right technology in place.

Company News Release


Applied Clinical Trials


Applied Clinical Trials


Applied Clinical Trials
Rasi was forced to step down in November 2014 by the EU Civil Service Tribunal after a panel of experts found the European Commission (EC) had used improper procedures when it had selected him back in 2011.

Applied Clinical Trials
Aligning patient-centric approaches with personalized medicine and biomarker use is transforming the design of Alzheimer's trials.

Applied Clinical Trials
A review of public data indicates a small increase in Phase III inclusion/exclusion criteria per trial over a five-year period.

Applied Clinical Trials
This experimental technique is being studied to see whether it could treat certain health problems.

Applied Clinical Trials
Examining the practical significance of reporting patient deaths due to main disease progression.

Applied Clinical Trials
Using a specific trial, the importance of assessing the success of therapy masking is examined.

Applied Clinical Trials
Survey applies rigorous analysis to provide a rare formal look at volunteer satisfaction in early setting.

Applied Clinical Trials
Trial Design: Gene Transfer: Key Challenges Therapy Masking Assessment Safety Reporting: Death Waivers Fall Short Subject Engagement: Phase I Satisfaction Scores Also in this issue: Informed Consent Changes in Works Europe's Embrace of New Science Alzheimer's and Patient Safety

Applied Clinical Trials E-Books
As the use of PRO expands in clinical trials, ePRO vendors themselveshave expanded beyond this constrained definition. Increasingly, the use of eCOA is being used to encompass all data collected related to the patient, which includes PRO, clinician reported (ClinRO) and observer or caregiver reported outcomes (ObsRO). Further, with mobile health technology use growing in general healthcare, that use is changing outcomes data collection in clinical trials. This e-Book tackles the changing world of PRO collection in clinical trials.

Applied Clinical Trials


Company News Release

Applied Clinical Trials


Applied Clinical Trials

Company News Release

Applied Clinical Trials

Company News Release

Applied Clinical Trials
PCCTC will utilize its services for the review of its cancer research protocols and related study documents.
